Annual report
4021.TEDINET S100YIML
Period2025-04-01 → 2026-03-31
Filed2026-06-24
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥279.6bn | 2025-04-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥251.4bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥226.7bn | 2023-04-01 → 2024-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥228.1bn | 2022-04-01 → 2023-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥208.0bn | 2021-04-01 → 2022-03-31v | Cons. | Net sales (5-year summary) |
| Operating income | ¥63.6bn | 2025-04-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | ¥56.8bn | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | ¥65.9bn | 2025-04-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥58.0bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥51.6bn | 2023-04-01 → 2024-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥55.8bn | 2022-04-01 → 2023-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥53.7bn | 2021-04-01 → 2022-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥65.9bn | 2025-04-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥59.5bn | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥49.7bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥43.0bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥38.0bn | 2023-04-01 → 2024-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥41.1bn | 2022-04-01 → 2023-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥38.8bn | 2021-04-01 → 2022-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥50.5bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | ¥43.0bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥355.1bn | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥330.8bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥323.5bn | at 2024-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥298.8bn | at 2023-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥279.7bn | at 2022-03-31v | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥96.0bn | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥94.6bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥259.1bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥236.2bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥231.0bn | at 2024-03-31v | Cons. | Net assets |
| Net assets / equity | ¥221.6bn | at 2023-03-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥208.1bn | at 2022-03-31v | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥35.7bn | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥27.5bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥35.7bn | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥27.5bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥22.7bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥29.6bn | at 2023-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥34.7bn | at 2022-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥64.2bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥59.2bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥33.7bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥35.2bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥41.9bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥21.2bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥17.6bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥18.7bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥19.6bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥12.4bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥36.2bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥35.6bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥22.1bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥25.0bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥27.9bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥368.26 | 2025-04-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥313.26 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥272.82 | 2023-04-01 → 2024-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥291.36 | 2022-04-01 → 2023-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥271.88 | 2021-04-01 → 2022-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥1,903.42 | at 2026-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,711.83 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,641.4 | at 2024-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,557.48 | at 2023-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,454.36 | at 2022-03-31v | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 71.9% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.5% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.3% | at 2024-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.1% | at 2023-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.6% | at 2022-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 20.3% | 2025-04-01 → 2026-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 18.7% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 17.1% | 2023-04-01 → 2024-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 19.4% | 2022-04-01 → 2023-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 19.2% | 2021-04-01 → 2022-03-31v | Cons. | Rate of return on equity (5-year summary) |
| Employees | 3,411 | at 2026-03-31 | Cons. | Number of employees |
| Employees | 3,283 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 3,137 | at 2024-03-31v | Cons. | Number of employees |
| Employees | 2,965 | at 2023-03-31v | Cons. | Number of employees |
| Employees | 2,737 | at 2022-03-31v | Cons. | Number of employees |
| Revenue | ¥217.8bn | 2025-04-01 → 2026-03-31 | Standalone | Net sales |
| Revenue | ¥201.6bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥181.2bn | 2023-04-01 → 2024-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥183.2bn | 2022-04-01 → 2023-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥170.0bn | 2021-04-01 → 2022-03-31v | Standalone | Net sales (5-year summary) |
| Operating income | ¥50.8bn | 2025-04-01 → 2026-03-31 | Standalone | Operating income |
| Operating income | ¥47.1bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Ordinary income | ¥55.8bn | 2025-04-01 → 2026-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥49.6bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥45.0bn | 2023-04-01 → 2024-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥46.4bn | 2022-04-01 → 2023-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥46.5bn | 2021-04-01 → 2022-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥55.8bn | 2025-04-01 → 2026-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥48.7bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Net income | ¥43.3bn | 2025-04-01 → 2026-03-31 | Standalone | Profit loss |
| Net income | ¥36.6bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥34.6bn | 2023-04-01 → 2024-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥36.2bn | 2022-04-01 → 2023-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥34.4bn | 2021-04-01 → 2022-03-31v | Standalone | Net income loss (5-year summary) |
| Total assets | ¥273.8bn | at 2026-03-31 | Standalone | Assets |
| Total assets | ¥259.0bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥257.6bn | at 2024-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥241.8bn | at 2023-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥231.0bn | at 2022-03-31v | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥82.3bn | at 2026-03-31 | Standalone | Liabilities |
| Total liabilities | ¥80.7bn | at 2025-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥191.5bn | at 2026-03-31 | Standalone | Net assets |
| Net assets / equity | ¥178.3bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥177.0bn | at 2024-03-31v | Standalone | Net assets |
| Net assets / equity | ¥174.7bn | at 2023-03-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥168.4bn | at 2022-03-31v | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥14.7bn | at 2026-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥14.4bn | at 2025-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥320.5 | 2025-04-01 → 2026-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥266.46 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥248 | 2023-04-01 → 2024-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥256.49 | 2022-04-01 → 2023-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥241.21 | 2021-04-01 → 2022-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥202 | 2025-04-01 → 2026-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥174 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥164 | 2023-04-01 → 2024-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥164 | 2022-04-01 → 2023-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥122 | 2021-04-01 → 2022-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,427.67 | at 2026-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,308.32 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,277.1 | at 2024-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,245.72 | at 2023-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,188.84 | at 2022-03-31v | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 69.9% | at 2026-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 68.8% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 68.7% | at 2024-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.3% | at 2023-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.9% | at 2022-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 23.4% | 2025-04-01 → 2026-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 20.6% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 19.7% | 2023-04-01 → 2024-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 21.1% | 2022-04-01 → 2023-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 20.6% | 2021-04-01 → 2022-03-31v | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 134,800,000 | at 2026-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 136,800,000 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 138,800,000 | at 2024-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 141,300,000 | at 2023-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 143,000,000 | at 2022-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Employees | 2,107 | at 2026-03-31 | Standalone | Number of employees |
| Employees | 2,044 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 2,011 | at 2024-03-31v | Standalone | Number of employees |
| Employees | 1,959 | at 2023-03-31v | Standalone | Number of employees |
| Employees | 1,929 | at 2022-03-31v | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 122
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | capex | 2025-04-01 → 2026-03-31 | ¥2.0bn |
| Otherother segments | depreciation | 2025-04-01 → 2026-03-31 | ¥1.3bn |
| Otherother segments | employees | at 2026-03-31 | 537 pure |
| Otherother segments | revenue | 2025-04-01 → 2026-03-31 | ¥31.8bn |
| Otherother segments | revenue external | 2025-04-01 → 2026-03-31 | ¥15.5bn |
| Otherother segments | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥16.2bn |
| Otherother segments | segment assets | at 2026-03-31 | ¥25.3bn |
| Otherother segments | segment profit | 2025-04-01 → 2026-03-31 | ¥2.0bn |
| Reconciling Itemsreconciling | capex | 2025-04-01 → 2026-03-31 | ¥1.0bn |
| Reconciling Itemsreconciling | depreciation | 2025-04-01 → 2026-03-31 | ¥597m |
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2026-03-31 | −¥135.2bn |
| Reconciling Itemsreconciling | revenue external | 2025-04-01 → 2026-03-31 | −¥25.8bn |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2026-03-31 | −¥109.5bn |
| Reconciling Itemsreconciling | segment assets | at 2026-03-31 | ¥45.5bn |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2026-03-31 | −¥6.1bn |
| Agrochemicalsreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥2.0bn |
| Agrochemicalsreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥3.9bn |
| Agrochemicalsreportable segment | employees | at 2026-03-31 | 753 pure |
| Agrochemicalsreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥96.2bn |
| Agrochemicalsreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥82.1bn |
| Agrochemicalsreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥14.1bn |
| Agrochemicalsreportable segment | segment assets | at 2026-03-31 | ¥111.5bn |
| Agrochemicalsreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥26.0bn |
| Chemicalsreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥3.0bn |
| Chemicalsreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥2.8bn |
| Chemicalsreportable segment | employees | at 2026-03-31 | 383 pure |
| Chemicalsreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥39.3bn |
| Chemicalsreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥26.2bn |
| Chemicalsreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥13.1bn |
| Chemicalsreportable segment | segment assets | at 2026-03-31 | ¥33.8bn |
| Chemicalsreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥1.1bn |
| Medicinesreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥661m |
| Medicinesreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥472m |
| Medicinesreportable segment | employees | at 2026-03-31 | 110 pure |
| Medicinesreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥5.2bn |
| Medicinesreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥5.1bn |
| Medicinesreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥91m |
| Medicinesreportable segment | segment assets | at 2026-03-31 | ¥8.4bn |
| Medicinesreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥1.4bn |
| Performance Materialsreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥9.8bn |
| Performance Materialsreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥6.2bn |
| Performance Materialsreportable segment | employees | at 2026-03-31 | 1039 pure |
| Performance Materialsreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥113.4bn |
| Performance Materialsreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥78.3bn |
| Performance Materialsreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥35.1bn |
| Performance Materialsreportable segment | segment assets | at 2026-03-31 | ¥77.2bn |
| Performance Materialsreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥35.3bn |
| Tradingreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥44m |
| Tradingreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥90m |
| Tradingreportable segment | employees | at 2026-03-31 | 229 pure |
| Tradingreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥128.9bn |
| Tradingreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥98.0bn |
| Tradingreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥30.8bn |
| Tradingreportable segment | segment assets | at 2026-03-31 | ¥53.4bn |
| Tradingreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥3.8bn |
| —segment total | capex | 2025-04-01 → 2026-03-31 | ¥17.5bn |
| —segment total | depreciation | 2025-04-01 → 2026-03-31 | ¥14.8bn |
| —segment total | revenue | 2025-04-01 → 2026-03-31 | ¥414.8bn |
| —segment total | revenue external | 2025-04-01 → 2026-03-31 | ¥305.3bn |
| —segment total | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥109.5bn |
| —segment total | segment assets | at 2026-03-31 | ¥309.6bn |
| —segment total | segment profit | 2025-04-01 → 2026-03-31 | ¥69.7bn |
| Otherother segments | capex | 2024-04-01 → 2025-03-31 | ¥1.9bn |
| Otherother segments | depreciation | 2024-04-01 → 2025-03-31 | ¥976m |
| Otherother segments | revenue | 2024-04-01 → 2025-03-31 | ¥29.2bn |
| Otherother segments | revenue external | 2024-04-01 → 2025-03-31 | ¥11.4bn |
| Otherother segments | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥17.7bn |
| Otherother segments | segment assets | at 2025-03-31 | ¥20.5bn |
| Otherother segments | segment profit | 2024-04-01 → 2025-03-31 | ¥594m |
| Reconciling Itemsreconciling | capex | 2024-04-01 → 2025-03-31 | ¥1.1bn |
| Reconciling Itemsreconciling | depreciation | 2024-04-01 → 2025-03-31 | ¥574m |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2025-03-31 | −¥125.1bn |
| Reconciling Itemsreconciling | revenue external | 2024-04-01 → 2025-03-31 | −¥25.9bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2025-03-31 | −¥99.2bn |
| Reconciling Itemsreconciling | segment assets | at 2025-03-31 | ¥42.4bn |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2025-03-31 | −¥5.4bn |
| Agrochemicalsreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥1.7bn |
| Agrochemicalsreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥2.8bn |
| Agrochemicalsreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥86.2bn |
| Agrochemicalsreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥70.7bn |
| Agrochemicalsreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥15.5bn |
| Agrochemicalsreportable segment | segment assets | at 2025-03-31 | ¥115.2bn |
| Agrochemicalsreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥25.9bn |
| Chemicalsreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥5.6bn |
| Chemicalsreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥2.9bn |
| Chemicalsreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥37.8bn |
| Chemicalsreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥25.2bn |
| Chemicalsreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥12.7bn |
| Chemicalsreportable segment | segment assets | at 2025-03-31 | ¥33.5bn |
| Chemicalsreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥369m |
| Medicinesreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥407m |
| Medicinesreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥404m |
| Medicinesreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥6.0bn |
| Medicinesreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥5.9bn |
| Medicinesreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥92m |
| Medicinesreportable segment | segment assets | at 2025-03-31 | ¥8.5bn |
| Medicinesreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥1.9bn |
| Performance Materialsreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥3.8bn |
| Performance Materialsreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥6.5bn |
| Performance Materialsreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥100.1bn |
| Performance Materialsreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥73.6bn |
| Performance Materialsreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥26.5bn |
| Performance Materialsreportable segment | segment assets | at 2025-03-31 | ¥65.9bn |
| Performance Materialsreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥29.3bn |
| Tradingreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥292m |
| Tradingreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥86m |
| Tradingreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥117.2bn |
| Tradingreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥90.4bn |
| Tradingreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥26.7bn |
| Tradingreportable segment | segment assets | at 2025-03-31 | ¥44.7bn |
| Tradingreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥4.1bn |
| —segment total | capex | 2024-04-01 → 2025-03-31 | ¥13.6bn |
| —segment total | depreciation | 2024-04-01 → 2025-03-31 | ¥13.7bn |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥376.5bn |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥277.3bn |
| —segment total | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥99.2bn |
| —segment total | segment assets | at 2025-03-31 | ¥288.4bn |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | ¥62.2bn |
| Agrochemicalsreportable segment | employees | at 2026-03-31 | 579 pure |
| Chemicalsreportable segment | employees | at 2026-03-31 | 383 pure |
| Medicinesreportable segment | employees | at 2026-03-31 | 110 pure |
| Performance Materialsreportable segment | employees | at 2026-03-31 | 675 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,990
| Item | Context | Value | Unit |
|---|---|---|---|
| Purchase of treasury stock fin cf | CurrentYearDuration | -10500000000 | JPY |
| Other net fin cf | Prior1YearDuration | -10000000 | JPY |
| Other net fin cf | CurrentYearDuration | -27000000 | JPY |
| Net cash provided by used in financing activities | Prior1YearDuration | -35650000000 | JPY |
| Net cash provided by used in financing activities | CurrentYearDuration | -36162000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YearDuration | -1215000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYearDuration | 1451000000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YearDuration | 4699000000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYearDuration | 8274000000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 22738000000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 27454000000 | JPY |
| Increase in cash and cash equivalents from newly consolidated subsidiary cce | Prior1YearDuration | 17000000 | JPY |
| Increase in cash and cash equivalents from newly consolidated subsidiary cce | CurrentYearDuration | － | JPY |
| Cash and cash equivalents | Prior1YearInstant | 27454000000 | JPY |
| Cash and cash equivalents | CurrentYearInstant | 35729000000 | JPY |
| Number of consolidated subsidiaries | CurrentYearInstant | 13 | |
| Number of associates accounted for using equity method | CurrentYearInstant | 3 | |
| Notes receivable trade | Prior1YearInstant | 4355000000 | JPY |
| Notes receivable trade | CurrentYearInstant | 4061000000 | JPY |
| Accounts receivable trade | Prior1YearInstant | 84775000000 | JPY |
| Accounts receivable trade | CurrentYearInstant | 93065000000 | JPY |
| Contract assets | Prior1YearInstant | － | JPY |
| Contract assets | CurrentYearInstant | 40000000 | JPY |
| Contract liabilities | Prior1YearInstant | 112000000 | JPY |
| Contract liabilities | CurrentYearInstant | 165000000 | JPY |
| Transportation expenses oerwy | Prior1YearDuration | 1161000000 | JPY |
| Transportation expenses oerwy | CurrentYearDuration | 1279000000 | JPY |
| Labor cost sga | Prior1YearDuration | 18649000000 | JPY |
| Labor cost sga | CurrentYearDuration | 19877000000 | JPY |
| Retirement benefit expenses labor cost sga | Prior1YearDuration | 525000000 | JPY |
| Retirement benefit expenses labor cost sga | CurrentYearDuration | 419000000 | JPY |
| Provision for compensation labor cost sga | Prior1YearDuration | 1854000000 | JPY |
| Provision for compensation labor cost sga | CurrentYearDuration | 2017000000 | JPY |
| Provision for share based remuneration for directors and other officers sga | Prior1YearDuration | 14000000 | JPY |
| Provision for share based remuneration for directors and other officers sga | CurrentYearDuration | 67000000 | JPY |
| Experiment cost sga | Prior1YearDuration | 4857000000 | JPY |
| Experiment cost sga | CurrentYearDuration | 5461000000 | JPY |
| Depreciation sga | Prior1YearDuration | 3203000000 | JPY |
| Depreciation sga | CurrentYearDuration | 5622000000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1YearDuration | 28000000 | JPY |
| Provision of allowance for doubtful accounts sga | CurrentYearDuration | 7000000 | JPY |
| Research and development expenses included in general and administrative expenses and manufacturing cost for current period | Prior1YearDuration | 19097000000 | JPY |
| Research and development expenses included in general and administrative expenses and manufacturing cost for current period | CurrentYearDuration | 21376000000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E00759-000ChemicalsReportableSegmentsMember | 25158000000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E00759-000PerformanceMaterialsReportableSegmentsMember | 73614000000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E00759-000AgrochemicalsReportableSegmentsMember | 70711000000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E00759-000MedicinesReportableSegmentsMember | 5901000000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E00759-000TradingReportableSegmentsMember | 90428000000 | JPY |
| Revenues from external customers | Prior1YearDuration_OtherReportableSegmentsMember | 11450000000 | JPY |
| Revenues from external customers | Prior1YearDuration_ReportableSegmentsMember | 277265000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |